Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023

BUY
$0.54 - $21.75 $12,848 - $517,497
23,793 New
23,793 $16,000
Q2 2022

Aug 09, 2022

BUY
$6.1 - $7.15 $186,757 - $218,904
30,616 New
30,616 $33,000
Q4 2021

Feb 17, 2022

SELL
$6.04 - $8.03 $120,975 - $160,832
-20,029 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$8.02 - $11.0 $160,632 - $220,319
20,029 New
20,029 $106,000
Q2 2021

Sep 17, 2021

SELL
$7.59 - $10.48 $99,489 - $137,371
-13,108 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$6.86 - $9.24 $19,310 - $26,010
2,815 Added 27.35%
13,108 $93,000
Q4 2020

Feb 24, 2021

BUY
$5.0 - $7.5 $51,465 - $77,197
10,293 New
10,293 $80,000

About Cyclacel Pharmaceuticals, Inc.


  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $7.9M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.